Benazir was shot
December 31st, 2007 by 
Luis Posted in Uncategorized | 
Comments Off
SaddamGate - now Lilly join the party
December 31st, 2007 by Luis
A third Big Pharma said Sunday it is being investigated by Britain's Serious Fraud Office (SFO) over alleged breaches of the United Nations oil-for-food programme in Saddam Hussein's Iraq.
Eli Lilly and Company Limited said it had been asked to hand over documents to the SFO, a day after GlaxoSmithKline and AstraZeneca announced they had received similar requests.Sphere: Related Content
Eli Lilly and Company Limited said it had been asked to hand over documents to the SFO, a day after GlaxoSmithKline and AstraZeneca announced they had received similar requests.Sphere: Related Content
Posted in Uncategorized | Comments Off
What will 2008 bring to Western Big Pharma?
December 30th, 2007 by Luis
Not much!
WuXi Pharmatech Inc., a decade-old drug research company in the industrial outskirts of Shanghai, will employ more chemists next year than Pfizer Inc., the world's largest producer of medicines.
``You have to have your own discovery capabilities, but you also increasingly need to source externally in order to access science and innovation,'' said James Ward-Lilley, president of AstraZeneca's operations in China, in an interview in his Shanghai office.
In China, personnel and supplies can cost 60 percent less than in the U.S., according to Boston Consulting Group. A two- month primate study to test a drug's toxicity may run $20,000 there, a 10th as much as in the U.S., according to the consulting firm Ernst & Young LLP in New York.
Entry-level scientists at WuXi make $35,000 a year, while Pfizer pays equivalent workers in the U.S. more than $90,000. The lower wages mean WuXi can hire more people and get jobs done faster.
It employs 2,500 scientists and chemists.
More at BloombergSphere: Related Content
WuXi Pharmatech Inc., a decade-old drug research company in the industrial outskirts of Shanghai, will employ more chemists next year than Pfizer Inc., the world's largest producer of medicines.
``You have to have your own discovery capabilities, but you also increasingly need to source externally in order to access science and innovation,'' said James Ward-Lilley, president of AstraZeneca's operations in China, in an interview in his Shanghai office.
In China, personnel and supplies can cost 60 percent less than in the U.S., according to Boston Consulting Group. A two- month primate study to test a drug's toxicity may run $20,000 there, a 10th as much as in the U.S., according to the consulting firm Ernst & Young LLP in New York.
Entry-level scientists at WuXi make $35,000 a year, while Pfizer pays equivalent workers in the U.S. more than $90,000. The lower wages mean WuXi can hire more people and get jobs done faster.
It employs 2,500 scientists and chemists.
More at BloombergSphere: Related Content
Posted in Uncategorized | Comments Off
